Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc.

BALA CYNWYD, Pa.--(BUSINESS WIRE)-- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Epocrates, Inc. ("Epocrates" or the "Company") (NAS: EPOC) relating to the proposed acquisition by AthenaHealth, Inc. ("AthenaHealth").

Under the terms of the transaction, Epocrates shareholders will receive only $11.75 in cash for each share of Epocrates stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Epocrates for not acting in the Company's shareholders' best interests in connection with the sale process to AthenaHealth. The transaction may undervalue the Company and will result in a loss for many shareholders. For example Epocrates stock traded at $25.80 as recently as March 15, 2011. In addition, an analyst has set a price target for Epocrates stock at $15.00 per share and the Epocrates app is used by approximately 338,000 U.S. physicians.


If you own shares of Epocrates stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/526-epoc-epocrates-inc.html, by calling toll free 877-LEGAL-90.



Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
877-LEGAL-90
investorrelations@brodsky-smith.com
http://brodsky-smith.com/526-epoc-epocrates-inc.html

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:

The article Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc. originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Investing in Emerging Markets

Learn to invest in a globalized world.

View Course »

Investor’s Toolbox

Improve your investing savvy with the right financial toolset.

View Course »

Add a Comment

*0 / 3000 Character Maximum